Shorts

1:17
Navigating Early Treatment Access After Promising Trial Data
12 hours ago
by
David Savage, MD, PhD

0:35
Your Wednesday Wrap-Up - August 19
15 hours ago
by
Sabrina Serani

0:35
Why "Asian American" Isn't Just One Medical Category
a day ago
by
Scarlett Lin Gomez, PhD, MPH

0:42
Targeting Breast Cancer's Nerve Connection
2 days ago
by
Jumana Abbadi, MD

0:32
A Surprising New Insight on How Breast Cancer Spreads
3 days ago

0:46
Can Operations Keep Pace With Oncology’s Outpatient Expansion?
4 days ago
by
Donna Berizzi, RN, DNP, OCN, NEA-BC

1:17
The Link Between Inflammation, Aging, and Cancer
6 days ago
by
Hearn Jay Cho, MD, PhD

0:34
An Often-Missed Early Step in Myeloma Care
7 days ago
by
Sagar Lonial, MD

0:17
Your Wednesday Wrap-Up - August 12th
8 days ago

0:34
Can We Cure Lung Cancer With Shorter Immunotherapy Treatment?
9 days ago
by
Ravi Salgia, MD, PhD

0:54
The Growing Case for ePROs in Community Oncology
9 days ago
by
Debra Patt, MD, PhD, MBA

0:50
Does ENDURANCE Support Lenalidomide Discontinuation At 2 Years?
10 days ago
by
Sagar Lonial, MD

0:41
OncoPRO Helps Practices Navigate ePRO Adoption
10 days ago
by
Debra Patt, MD, PhD, MBA

0:43
Can We Make Stage IV Lung Cancer Curable? New Research Offers Hope
12 days ago
by
Ravi Salgia, MD, PhD

0:36
ePRO Monitoring: Earlier Intervention, Fewer Hospitalizations
12 days ago
by
Debra Patt, MD, PhD, MBA

0:30
Why the Future of Oncology Looks Brighter Than Ever
13 days ago
by
Ravi Salgia, MD, PhD

0:43
The Future of Myeloma Care: Home Administration
13 days ago
by
Joseph Mikhael, MD

0:35
GLP-1s Linked to 34% Lower Cancer Mortality Rate
14 days ago
by
Jess Paulus, ScD

0:26
Your Wednesday Wrap-Up
15 days ago
by
Sabrina Serani

1:08
Reacting to the FDA Advisory Committee Verdict on RP1 in Melanoma
15 days ago
by
Vincent Ma, MD

0:42
Could GLP-1s Have Anticancer Effects?
15 days ago
by
Jess Paulus, ScD

1:04
Breaking Free From Infusion Centers With SC Myeloma Treatment
16 days ago
by
Joseph Mikhael, MD

0:35
Breakthough in Long-Term TNBC Management With KEYNOTE-522
16 days ago
by
Javier Cortés, MD, PhD

0:31
Why Standardized Oncology Care is a Global Necessity
16 days ago
by
Daniel Araujo, MD

0:42
Uncovering the Secrets of Tumor Resistance
17 days ago
by
Edgardo Santos Castillero, MD, FACP, FASCO

0:50
Is Oncology Ready for Multi-Cancer Blood Tests?
20 days ago
by
Ranjit Goudar, MD

0:50
Most Women Don't Know This Major Cancer Risk
20 days ago
by
Darren Mays, PhD, MPH

0:33
Genetic Testing Isn’t the End of the Story
21 days ago
by
Ranjit Goudar, MD

0:43
Why the VIKTORIA-1 Study Matters in Breast Cancer
21 days ago
by
Erica Stringer-Reasor, MD

0:42
The Necessary Shift From Cancer Treatment to Early Detection
22 days ago
by
Ranjit Goudar, MD
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
mRNA Vaccine Plus Pembrolizumab Yields RFS, DMFS Benefit in Resectable Melanoma
2
FDA Grants ETX-19477 Fast Track Designation in BRCA-Mutated Breast Cancer
3
FDA Grants Fast Track Designation to Piktor in Endometrial Cancer
4
FDA Grants Fast Track Designation to BH-30643 in EGFR C797S+ NSCLC
5
